We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+12.53%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$21.3B
AUM Growth
+$4.08B
(+24%)
Cap. Flow
+$2.12B
Cap. Flow
% of AUM
9.98%
Top 10 Holdings %
Top 10 Hldgs %
58.73%
Holding
1,162
New
154
Increased
426
Reduced
439
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$1.51B |
| 2 |
Western Midstream Partners
WES
|
+$147M |
| 3 |
NexGen Energy
NXE
|
+$124M |
| 4 |
Eaton Vance Total Return Bond ETF
EVTR
|
+$52.4M |
| 5 |
Freeport-McMoran
FCX
|
+$51.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uranium Energy
UEC
|
+$123M |
| 2 |
Plains All American Pipeline
PAA
|
+$59.9M |
| 3 |
AngloGold Ashanti
AU
|
+$35.3M |
| 4 |
Royal Gold
RGLD
|
+$30.5M |
| 5 |
Harmony Gold Mining
HMY
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 68.07% |
| 2 | Materials | 6.1% |
| 3 | Technology | 3.07% |
| 4 | Financials | 2.69% |
| 5 | Utilities | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Transmedics
TMDX
$2.5B
| $399K | ﹤0.01% |
4,011
-3
| -0.1% | -$391 |
|
952
Apogee Enterprises
APOG
$850M
| $399K | ﹤0.01% |
11,887
-1,240
| -9% | -$45.9K |
|
953
Intel
INTC
$464B
| $397K | ﹤0.01% |
+8,998
| New | +$412K |
|
|
UPB
954
Upstream Bio Inc
UPB
$349M
| $396K | ﹤0.01% |
43,992
-384
| -0.9% | -$6.91K |
|
955
Credo Technology Group
CRDO
$39.7B
| $395K | ﹤0.01% |
4,207
+1,366
| +48% | +$166K |
|
956
Marriott International
MAR
$98.7B
| $393K | ﹤0.01% |
+1,201
| New | +$395K |
|
957
Consensus Cloud Solutions
CCSI
$669M
| $391K | ﹤0.01% |
+16,480
| New | +$424K |
|
958
Taylor Devices
TAYD
$175M
| $379K | ﹤0.01% |
+6,650
| New | +$511K |
|
959
Devon Energy
DVN
$51.9B
| $371K | ﹤0.01% |
7,369
-14,000
| -66% | -$600K |
|
960
Progress Software
PRGS
$1.55B
| $370K | ﹤0.01% |
+14,440
| New | +$552K |
|
961
Aclaris Therapeutics
ACRS
$730M
| $368K | ﹤0.01% |
98,175
+9,209
| +10% | +$31.1K |
|
962
Innovative Solutions & Support
ISSC
$342M
| $367K | ﹤0.01% |
+17,870
| New | +$414K |
|
963
Regenxbio
RGNX
$623M
| $352K | ﹤0.01% |
42,012
+444
| +1% | +$4.67K |
|
964
Camden Property Trust
CPT
$11.3B
| $351K | ﹤0.01% |
3,590
-375
| -9% | -$39.8K |
|
965
Atea Pharmaceuticals
AVIR
$379M
| $349K | ﹤0.01% |
64,862
+708
| +1% | +$3.25K |
|
966
Sibanye-Stillwater
SBSW
$5.92B
| $339K | ﹤0.01% |
+27,487
| New | +$428K |
|
967
EVgo
EVGO
$202M
| $337K | ﹤0.01% |
195,641
+12,242
| +7% | +$32.7K |
|
968
Vanda Pharmaceuticals
VNDA
$312M
| $332K | ﹤0.01% |
48,116
-406
| -0.8% | -$3.13K |
|
969
Wells Fargo
WFC
$261B
| $332K | ﹤0.01% |
4,169
-525
| -11% | -$45.1K |
|
|
NMG
970
Nouveau Monde Graphite
NMG
$415M
| $328K | ﹤0.01% |
146,212
+64,635
| +79% | +$158K |
|
971
Equity Lifestyle Properties
ELS
$12.8B
| $327K | ﹤0.01% |
5,232
| – | – |
|
972
Altimmune
ALT
$539M
| $326K | ﹤0.01% |
105,881
+20,204
| +24% | +$85.8K |
|
973
IQVIA
IQV
$34.7B
| $318K | ﹤0.01% |
1,863
| – | – |
|
974
Ethan Allen Interiors
ETD
$581M
| $318K | ﹤0.01% |
14,270
-1,485
| -9% | -$34.5K |
|
975
Invitation Homes
INVH
$17.7B
| $304K | ﹤0.01% |
12,216
-1,273
| -9% | -$33.3K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ALPS Advisors held 1,162 positions worth $21.3B, up 24% from $17.2B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
ALPS Advisors deployed $2.12B of net new capital in Q1 2026, opening 154 new positions and adding to 426 existing holdings. Its largest new stake was Eaton Vance Total Return Bond ETF: 1,017,240 shares worth $51.6M.
By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 63% a quarter earlier, followed by Materials and Technology.
On the sell side, the largest reduction was Uranium Energy, an estimated $123M trimmed.
- ALPS Advisors's largest Q1 2026 buy was Eaton Vance Total Return Bond ETF: 1,017,240 shares worth $51.6M.
- ALPS Advisors added most to MPLX in Q1 2026, an estimated $1.51B increase.
- ALPS Advisors's biggest Q1 2026 reduction was Uranium Energy, cutting an estimated $123M.
- ALPS Advisors fully exited Columbia EM Core ex-China ETF in Q1 2026, selling an estimated $15.5M.
- ALPS Advisors's ten largest holdings make up 59% of its $21.3B portfolio in Q1 2026.
- ALPS Advisors opened 154 new positions and closed 125 in Q1 2026.
- ALPS Advisors's portfolio value rose 24% quarter-over-quarter to $21.3B.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.